The proton resonance enhancement for CEST imaging and shift exchange ( PRECISE ) family of RF pulse shapes for CEST MRI
Magnetic Resonance in Medicine · 2025
DOI: 10.1002/mrm.30410 ↗Kurz gefasst
Fachartikel in der Zeitschrift Magnetic Resonance in Medicine, 2025. Verfasst von Zinia Mohanta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Image Processing, Computer-Assisted. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIBIB NIH HHS, Division of Diabetes, Endocrinology, and Metabolic Diseases.
Abstract (Originalsprache)
Purpose
To optimize a 100 ms pulse for producing CEST MRI contrast and evaluate in mice.
Methods
A gradient ascent algorithm was employed to generate a family of 100 point, 100 ms pulses for use in CEST pulse trains (proton resonance enhancement for CEST imaging and shift exchange). Gradient ascent optimizations were performed for exchange rates = 500, 1500, 2500, 3500, and 4500 s −1 ; and labile proton offsets (Δω) = 9.6, 7.8, 4.2, and 2.0 ppm. Seven proton resonance enhancement for CEST imaging and shift exchange pulse shapes were tested on an 11.7 T scanner using a phantom containing three representative CEST agents with peak saturation B 1,peak = 4 μT. The pulse producing the most contrast in phantoms was then evaluated for CEST MRI pH mapping of the kidneys in healthy mice after iopamidol administration.
Results
The most promising pulse in terms of contrast performance across all three phantoms was the 9.6 ppm, 2500 s −1 optimized pulse with ˜2.7 × increase in asymmetric magnetization transfer ratio (MTR asym ) over Gaussian, and ˜ 1.3 times over Fermi pulses for the same B 1,peak = 4 μT. This pulse also displayed a large improvement in contrast over the Gaussian pulse after administration of iopamidol in live mice.
Conclusion
A new 100‐ms pulse was developed based on gradient ascent optimizations, which produced better contrast compared to standard Gaussian and Fermi pulses in phantoms. This shape also showed a substantial improvement for CEST MRI pH mapping in live mice over the Gaussian shape and appears promising for a wide range of CEST applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Research Institute, Baltimore, Maryland, USA.
- Department of Chemical Engineering and Materials Science, Michigan State University, East Lansing, Michigan, USA.
- Department of Radiology, Michigan State University, East Lansing, Michigan, USA.
ORCID-Profile: Julia Stabinska, Peter B Barker, Michael T McMahon
Förderung
- NIDDK NIH HHS
- NIBIB NIH HHS
- Division of Diabetes, Endocrinology, and Metabolic Diseases
- National Institute of Biomedical Imaging and Bioengineering
Zitieren
APA
Mohanta, Z., Stabinska, J., Gilad, A. A., Barker, P. B., & McMahon, M. T. (2025). The proton resonance enhancement for CEST imaging and shift exchange ( PRECISE ) family of RF pulse shapes for CEST MRI. Magnetic Resonance in Medicine. https://doi.org/10.1002/mrm.30410
Vancouver
Mohanta Z, Stabinska J, Gilad AA, Barker PB, McMahon MT. The proton resonance enhancement for CEST imaging and shift exchange ( PRECISE ) family of RF pulse shapes for CEST MRI. Magnetic Resonance in Medicine. 2025. doi:10.1002/mrm.30410
BibTeX
@article{Mohanta2025,
author = {Mohanta, Zinia and Stabinska, Julia and Gilad, Assaf A and Barker, Peter B and McMahon, Michael T},
title = {The proton resonance enhancement for CEST imaging and shift exchange ( PRECISE ) family of RF pulse shapes for CEST MRI},
journal = {Magnetic Resonance in Medicine},
year = {2025},
doi = {10.1002/mrm.30410}
}
EUVIMED